Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex

Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex

Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon...

Full description

Saved in:
Bibliographic Details
Main Authors: Renan Le Cras, Roseline Mazet, Fanny Dubois-Teklali, Cécile Sabourdy, Sébastien Chanoine, Audrey Lehmann, Agathe Morin, Julien Leenhardt, Marjorie Durand, Marie-Dominique Desruet, Pierrick Bedouch
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
Inosiplex
inosine pranobex
speciality commercially stopped
magistral preparation
subacute sclerosing panencephalitis (SSPE)
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2148563
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2148563

Similar Items